- Molecular analysis of sentinel lymph nodes in patients with breast cancer using one-step nucleic acid amplification (OSNA): Does not lead to overtreatment in the current era of de-escalating axillary management
K.F.H. Hintzen et al, 2020, Surgical Oncology CrossRef - One‐step nucleic acid amplification CK19 copy number for sentinel node biopsy in breast cancer: Identification of new cutoffs to predict nonsentinel axillary node involvement
Giulio Cuffolo et al, 2020, The Breast Journal CrossRef - Prediction of Non-sentinel Lymph Node Metastasis by One-step Nucleic Acid Amplification of Sentinel Lymph Nodes in Luminal Breast Cancer
Tomoo INOUE et al, 2022, Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) CrossRef - External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients
Antonio Piñero-Madrona et al, 2020, Breast Cancer Research and Treatment CrossRef - Intraoperative Pathological Examination of Breast Lesions
Ekrem Yavuz et al, 2019, Breast Cancer CrossRef - Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis
Sonia Martinez Alcaide et al, 2022, Archives of Gynecology and Obstetrics CrossRef - Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
Elisabeth R. M. van Haaren et al, 2023, Breast Cancer Research and Treatment CrossRef - Can one-step nucleic acid amplification assay predict four or more positive axillary lymph node involvement in breast cancer patients: a single-centre retrospective study
R Kenny et al, 2022, The Annals of The Royal College of Surgeons of England CrossRef - Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study
B. Vieites et al, 2021, Clinical and Translational Oncology CrossRef